You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 17, 2024

Details for Patent: 11,827,642


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,827,642 protect, and when does it expire?

Patent 11,827,642 protects AYVAKIT and is included in one NDA.

This patent has forty-seven patent family members in thirty-one countries.


Drugs Protected by US Patent 11,827,642

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Blueprint Medicines AYVAKIT avapritinib TABLET;ORAL 212608-004 Jun 16, 2021 RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y Y TREATMENT OF INDOLENT SYSTEMIC MASTOCYTOSIS (ISM) ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,827,642

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 098054 ⤷  Try a Trial
Australia 2014337314 ⤷  Try a Trial
Brazil 112016008541 ⤷  Try a Trial
Canada 2926999 ⤷  Try a Trial
China 105658652 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.